03 R&D Highlights Pablo Cagnoni, MD | Head of R&D Alexis Smith | VP, Investor Relations 04 Financial Results Tom Tray | Principal Financial Officer 06 Q&A Fourth Quarter & Full-Year 2025 Financial & Corporate Update FEBRUARY 10, 2026 Agenda 01 Introduction Bill Meury | Chief Executive Officer 05 Closing Remarks Bill Meury | Chief Executive Officer Steven Stein, MD | EVP, Chief Medical Officer Dave Gardner | EVP, Chief Strategy Officer Mohamed Issa | EVP, Head of US Oncology 02 Opening Remarks Matteo Trotta ...

Q4 2025 Update | Executive Summary | p.03 | | --- | --- | | Key Highlights | p.04 | | Financial Summary | p.06 | | MAUs & Subscribers | p.13 | | Product & Platform | p.16 | | Outlook | p.19 | Financial Statements p.22 2 Executive Summary We finished 2025 with strong performance, as all Q4 KPIs met or exceeded guidance to deliver strong Free Cash Flow*. The business added a record 38 million MAU vs. guidance for 32 million, while Subscriber net additions of 9 million exceeded guidance by 1 million. Revenue w ...

Operating & Financial Results Forth Quarter 2025 & FY2025 February 10, 2025 Chairman & CEO CFO Nangeng Zhang Jin "James" Cheng 1 Safe Harbor Statement This presentation contains certain financial measures that are not recognized under generally accepted accounting principles in the United States ("GAAP"), including adjusted EBITDA (including adjusted EBITDA margin), non-GAAP net income, non-GAAP diluted earnings per share/ADS and cash flow. These non-GAAP measures should be considered in addition to, and no ...

First Quarter Fiscal 2026 Page 2 SCOTTISH WATER ENTERPRISE ALLIANCE Scotland, United Kingdom AECOM was selected as a preferred bidder for the multi-billion-dollar investment program to enhance Scotland's water and wastewater infrastructure. Disclosures Forward-Looking Statements All statements in this communication other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws, including any statements of the plans, strategies and objectives for f ...

AstraZeneca (NasdaqGS:AZN) Q4 2025 Earnings call February 10, 2026 06:45 AM ET Company ParticipantsAndy Barnett - Head of Investor RelationsAradhana Sarin - CFODave Fredrickson - EVP, Oncology Business UnitGraham Parry - Head of Healthcare Equity ResearchIskra Reic - EVP, Europe & CanadaMarc Dunoyer - CEO, AlexionPascal Soriot - CEORajan Sharma - Executive Director, Pharma and Biotech Equity ResearchRuud Dobber - EVP, BioPharmaceuticals Business UnitSharon Barr - EVP, BioPharmaceuticals R&DSusan Galbraith - ...

AstraZeneca (NasdaqGS:AZN) Q4 2025 Earnings call February 10, 2026 06:45 AM ET Company ParticipantsAndy Barnett - Head of Investor RelationsAradhana Sarin - CFODave Fredrickson - EVP, Oncology Business UnitGraham Parry - Head of Healthcare Equity ResearchIskra Reic - EVP, Europe & CanadaMarc Dunoyer - CEO, AlexionPascal Soriot - CEORajan Sharma - Executive Director, Pharma and Biotech Equity ResearchRuud Dobber - EVP, BioPharmaceuticals Business UnitSharon Barr - EVP, BioPharmaceuticals R&DSusan Galbraith - ...

AstraZeneca (NasdaqGS:AZN) Q4 2025 Earnings call February 10, 2026 06:45 AM ET Speaker6Good morning to those joining from the U.K. and the U.S. Good afternoon to those in Central Europe, and good evening to those listening in Asia. Welcome, ladies and gentlemen, to AstraZeneca's full-year and Q4 2025 results conference call for investors and analysts. Before I hand over to AstraZeneca, I'd like to read the Safe Harbor statement. The company intends to utilize the Safe Harbor provisions of the United States ...

Proficient Auto Logistics Investor Presentation February 2026 Who We Are – Proficient Auto Logistics ("PAL") Top 2 Largest Auto Hauler(1) ~800 Dedicated Employees(2) ~2.3M Units Shipped 55+ Strategically Located Facilities 1,200+ Auto transport vehicles & trailers at our disposal daily >90% Automotive OEMs served for U.S. transport Source: Certain information is based on management estimates, which have been derived from third-party sources and internal research and are based on certain assumptions manageme ...

Leading the Multi-Orbit Revolution Investor Presentation February 2026 Gilat Proprietary and Confidential Gilat Proprietary and Confidential 3 Forward Looking Statements Disclaimer Certain statements made herein that are not historical are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words "estimate", "project", "intend", "expect", "believe" and similar expressions are intended to identify forward-looking statements. These forward- looking statements involv ...

Conference call agenda FY and Q4 2025 Results Conference call and webcast for investors and analysts 10 February 2026 Cautionary statements regarding forward-looking statements In order, among other things, to utilise the 'safe harbour' provisions of the US Private Securities Litigation Reform Act of 1995, AstraZeneca (hereafter 'the Group') provides the following cautionary statement: This document contains certain forward-looking statements with respect to the operations, performance and financial conditi ...